Paige Chamberlain
Stock Analyst at Wolfe Research
(2.22)
# 3,258
Out of 4,683 analysts
5
Total ratings
66.7%
Success rate
24.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Paige Chamberlain
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VCYT Veracyte | Rated: Buy | $55 | $44.29 | +24.18% | 1 | Jun 1, 2026 | |
| NTRA Natera | Rated: Buy | $260 | $338.45 | -23.18% | 1 | Jun 1, 2026 | |
| GH Guardant Health | Rated: Buy | $150 | $170.92 | -12.24% | 1 | Jun 1, 2026 | |
| GRAL GRAIL | Initiated Coverage: Hold | n/a | $79.59 | - | 1 | Jun 1, 2026 | |
| TEM Tempus AI | Initiated Coverage: Hold | n/a | $68.48 | - | 1 | Jun 1, 2026 |
Veracyte
Jun 1, 2026
Rated: Buy
Price Target: $55
Current: $44.29
Upside: +24.18%
Natera
Jun 1, 2026
Rated: Buy
Price Target: $260
Current: $338.45
Upside: -23.18%
Guardant Health
Jun 1, 2026
Rated: Buy
Price Target: $150
Current: $170.92
Upside: -12.24%
GRAIL
Jun 1, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $79.59
Upside: -
Tempus AI
Jun 1, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $68.48
Upside: -